DARPA: Harnessing Enzymatic Activity for Lifesaving Remedies (HEALR)
קרן | US Department of Defense |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 29/09/2020 |
פקולטה | Engineering, Life Sciences, Medicine |
תיאור | The goal of the HEALR program is to develop new medical countermeasures against bacterial pathogens and their toxins by leveraging host degradation and deactivation pathways. HEALR aims to develop: (1) tools to target microbial pathogens via protein degradation (i.e., target-binding ligand development); (2) innovative modalities to enable new pathways to protein degradation or deactivation; (3) a platform that leverages these advances to permit flexible and rapid response to emerging threats.
Funding: No fixed limit Duration: 54 months
Research Authority due date: 4.8.20 Abstract (strongly encouraged) due date:11.8.20 Full proposal due date:
|
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 01/09/2020 |